Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Aurora Cannabis Inc. buy nefets

Start price
€10.20
16.05.20 / 50%
Target price
€17.00
04.11.21
Performance (%)
-15.69%
End price
€8.60
20.03.21
Summary
This prediction ended on 20.03.21 with a price of €8.60. The price of Aurora Cannabis Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.69%. nefets has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Aurora Cannabis Inc. - - - -
iShares Core DAX® 1.804% -0.748% 13.168% 16.408%
iShares Nasdaq 100 -0.182% -3.412% 39.976% 43.502%
iShares Nikkei 225® 0.413% -7.381% 18.776% 2.874%
iShares S&P 500 0.664% -1.941% 28.141% 42.155%

According to nefets what are the pros and cons of Aurora Cannabis Inc. for the foreseeable future?

Pros
Undervalued
Sustainability is important
Very Future proof/growth oriented business model
Cons
Risky Investment
Revenue decline > 20% expected
EBIT decline/stagnation expected
Very low/no dividend yield expected
very negative Cash Flow expected
Junk rating
High risks in the balance sheet
ROE lower than 5% per year
High challenges to pay loans and raise capital
Deficits in Management
Very bad culture
Little innovation
Few uniques
Growths slower than the competition
high free float
High risks for its business
Below average Marketposition
Significant cyclical dependencies
Unknown brand

Comments by nefets for this prediction

In the thread Aurora Cannabis diskutieren
Prediction Buy
Perf. (%) -15.69%
Target price 17.000
Change
Ends at 04.11.21

Buy mit Kursziel 17,0

In the thread Trading Aurora Cannabis
Prediction Buy
Perf. (%) -15.69%
Target price 17.000
Change
Ends at 04.11.21

Buy beendet

Stopped prediction by nefets for Aurora Cannabis Inc.

Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€8.60
20.03.21
€5.00
04.11.21
-31.08%
05.11.21

Risky Investment
Revenue decline > 20% expected
EBIT decline/stagnation expected